Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Latest News about Psychedelics Research Recent news which mentions Psychedelics Research Can LSD Therapy Calm Anxious Dogs? First-Of-Its-Kind Study Uncovers New Possibilities September 27, 2024 Tickers DOGS PETS Tags LSD dogs Benzinga Market News From Benzinga Psilocybin Breakthrough: Study Reveals Potential Application For Body Dysmorphic Disorder September 26, 2024 Tickers CMPS NEWS Tags Psilocybin Psychedelics Health Care From Benzinga Non-Hallucinogenic Psychedelic Treatment For Anxiety And Depression In Pre-Clinical Models: Enveric Biosciences' Breakthrough Research September 25, 2024 Tickers CCC ENVB NEWS Tags Education ENVB Psychedelics Research From Benzinga DEA Boosts Psychedelics Production For Research, Cannabis Quotas Hold Steady Ahead Of Rescheduling September 24, 2024 Tickers NEWS Tags psilocyn Top Stories Regulations From Benzinga Fed Health Agency Funds $2.4M Study On Psychedelics Treatment For Meth Addiction August 28, 2024 Tickers NEWS Tags Benzinga National Institute on Drug Abuse Cannabis From Benzinga Podcast - Intro To A Toll-Free Psychedelics Information Line, An Educational Tool By Unlimited Sciences April 29, 2024 Tickers NEWS Tags Cannabis Unlimited Sciences Matthew Lowe From Benzinga Psychedelics Headlines: Dementia Prevention, Psychological Flexibility, Ancient Romans' Trips And More April 17, 2024 Tickers AWKNF BETRF CMND FLHLF Tags Psychedelics Research MNMD HUGE From Benzinga Psyched: DEA Revisits Ban On Two Psychedelics, Farewell Russell Newcombe, Podcast Episode On Kanna & More April 17, 2024 Tickers AGNPF ATAI CMND CMPS Tags LSDI ENVB CMPS From Benzinga Numinus Wellness Q2 2024 Revenue Declines Amid Clinic Reshuffling And Expected Industry Trends April 15, 2024 Tickers NEWS NUMIF Tags Earnings Biotech News From Benzinga Optimi To Supply Psilocybin For New Zealand's Mātai Medical Research Institute April 09, 2024 Tickers NEWS OPTHF Tags Cannabis New Zealand Psychedelics Market News From Benzinga Psychedelics Reform Update: Missouri's $10M Budget, Maine's & Maryland's Study Groups, Oregon's Re-Crim And More April 05, 2024 Tags Global Psychedelic/Assisted Therapies FDA From Benzinga DMT For Stroke Treatment: Algernon Sets Phase 2 Clinical Trial Design April 03, 2024 Tickers AGNPF Tags Psychedelics Research Human Stroke Management From Benzinga Psychedelics Headlines: A Form Of Life, Treating Chronic Pain, Microdosing And More March 30, 2024 Tickers CMND CMPS CYBN FLHLF Tags Psychedelics CMND Biotech From Benzinga Psyched: 5-MeO-DMT For Depression, Utah Hospitals Providing Therapy, Elon Musk And Meta's Influence March 29, 2024 Tickers ATAI CMND CMPS DRUG Tags TSLA Elon Musk Market News From Benzinga Atai Life Sciences Q4 And Full-Year 2023 Results: Steep Cash Drain Yet 2026 Target Remains, Update On Psychedelic Pipeline March 29, 2024 Tickers ATAI CMPS Tags ATAI Psychedelics Research CMPS From Benzinga Intranasal 5-MeO-DMT Clinical Trial Offers Hope For Treatment-Resistant Depression March 28, 2024 Tickers ATAI NEWS Tags ATAI Psychedelics Research News From Benzinga PharmAla's Novel MDMA Mixture Awarded US Patent, Enabling IP Protection And Further Development March 27, 2024 Tickers MDXXF Tags Benzinga MDMA treatment Global From Benzinga Two Top Biotechs Forge MDMA Supply Deals For Clinical Research March 26, 2024 Tickers MDXXF NEWS NUMIF OPTHF Tags Addiction Treatment News Psychedelics Research From Benzinga Utah Hospitals Will Soon Provide Psilocybin And MDMA Therapy For Mental Health Conditions March 25, 2024 Tickers NEWS NUMIF Tags Legal Psychedelics Research MDMA Therapy From Benzinga Congress Discusses Remaining FY2024 Spending Bill With Provisions On Cannabis Sales And Psychedelic Clinical Trials March 22, 2024 Tags Market News Cannabis B/C/ cannabis From Benzinga Psyched: LSD, Psilocybin As Breakthrough Therapies, $14M Fed Grant For Ibogaine, Indiana's Research And More March 20, 2024 Tickers ATAI CMND CMPS CYBN Tags Breakthrough Therapy Drug Biotech CMND From Benzinga Psychedelics Headlines: Substitution Survey, Frank Herbert's Magic Mushrooms, Celestial Plans And News Review March 16, 2024 Tickers ATAI BETRF CMND ENVB Tags NUMIF Benzinga Global From Benzinga Psyched: New Evidence Shows Psilocybin As Anxiety Therapy, Open-Source Learning For Therapists, Enveric's Licensing Deals And More March 04, 2024 Tickers ATAI CMND CMPS CYBN Tags SILO Market News PSIL From Benzinga Psychedelics Headlines: Predicting Readiness, Correcting The Hype, Good And Bad Drugs, Training Programs And More March 01, 2024 Tickers BRAXF FLHLF OPTHF SILFF Tags Market News Cannabis Psychedelic/Assisted Therapies From Benzinga Beckley Academy's Open-Source Psychedelic Therapy Learning Framework Is Out: What's It All About? Authoring Team Shares Insights February 29, 2024 Tags Psychedelics Management Health Care From Benzinga Psilocybin-Assisted Therapy Achieves Positive Clinical Trial Results For Treating Generalized Anxiety February 28, 2024 Tickers IXHL NEWS Tags Benzinga Market News Cannabis From Benzinga FDA Hosts Public Psychedelics Discussion, Discloses Major Growth On Number Of New Psychiatric Drugs Filings Post-2000 January 31, 2024 Tickers JNJ MNMD Tags Biotech Reagan/Udall Foundation for the FDA Events From Benzinga Psychedelics Headlines: Anti-inflammatory Effects, Global Drug Survey, 'Synthetic Surprise,' UK's Harm Reduction Hub And More January 26, 2024 Tickers AWKNF CMND CMPS FLHLF Tags Financing GHRS Biotech From Benzinga Psychedelics Headlines: MDMA & Coping Skills In PTSD, LSD's Perceived Risks, Knowledge Gaps, Surveys & More January 15, 2024 Tickers ATAI CMND CMPS CYBN Tags Markets News Psychedelics Reform From Benzinga DEA Acknowledges Psychedelics & Cannabis Research Needs, Seeks Production Increases November 01, 2023 Tags News Psychedelics Research Government From Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.